Skip to content

Kazuya Maeda

4 papers in the library · 363 citations · publishing 2011-2015

Papers

Sort Most recent Most cited

A clinical pharmacokinetic microdosing study of docetaxel with Japanese patients with cancer.

Cancer chemotherapy and pharmacology October 2015 Ken-ichi Fujita, Etsuko Yoshino, Kaori Kawara et al.

Whether microdosing studies can be used to evaluate the human pharmacokinetics of new anticancer drugs remains unclear. The disposition of docetaxel in cancer patients is linear in terms of dose proportionality. We examined whether the pharmacokinetics of docetaxel in a clinically relevant therapeutic dose could be predicted from the pharmacokinetics of a microdose of docetaxel in Japanese...

DOI: 10.1007/s00280-015-2844-2 (opens in new tab) Full text (opens in new tab) Docetaxel Microdose study Pharmacokinetics Α1-acid glycoprotein

Identification of the Rate-Determining Process in the Hepatic Clearance of Atorvastatin in a Clinical Cassette Microdosing Study

Clinical Pharmacology & Therapeutics August 10, 2011 Kazuya Maeda, Yasumasa Ikeda, Tomoe Fujita et al. 207 citations

Clearance of atorvastatin occurs through hepatic uptake by organic anion transporting polypeptides (OATPs) and subsequent metabolism by cytochrome P450 (CYP) 3A4. To demonstrate the relative importance of OATPs and CYP3A4 in the hepatic elimination of atorvastatin in vivo, a clinical cassette microdose study was performed. A cocktail consisting of a microdose of atorvastatin along with probe...

DOI: 10.1038/clpt.2011.142 (opens in new tab) Atorvastatin Pharmacology Microdose Cyp3a4 +10

Nonlinear Pharmacokinetics of Oral Quinidine and Verapamil in Healthy Subjects: A Clinical Microdosing Study

Clinical Pharmacology & Therapeutics June 29, 2011 Kazuya Maeda, Junichi Takano, Yasumasa Ikeda et al. 50 citations

Microdosing studies are effective in enabling the early identification of the pharmacokinetic properties of compounds administered to humans. However, the nonlinearity of the pharmacokinetics between microdose and therapeutic dose, attributable to the saturation of metabolic enzymes and transporters, is a major concern. Verapamil and quinidine are good substrates of both the multidrug...

DOI: 10.1038/clpt.2011.108 (opens in new tab) Quinidine Verapamil Pharmacokinetics Clinical pharmacology

Microdosing Clinical Study: Pharmacokinetic, Pharmacogenomic (SLCO2B1), and Interaction (Grapefruit Juice) Profiles of Celiprolol Following the Oral Microdose and Therapeutic Dose

The Journal of Clinical Pharmacology May 19, 2011 Ichiro Ieiri, Yohei Doi, Kazuya Maeda et al. 106 citations

The authors evaluated the contribution of the SLCO2B1 polymorphism to the pharmacokinetics of celiprolol at a microdose (MD) and therapeutic dose (TD) and compared pharmacokinetic proportionality between the 2 dose forms in 30 SLCO2B1 genotype-matched healthy volunteers. Three drugs (celiprolol, fexofenadine, and atenolol) were orally administered as a cassette dosing following the MD (totally...

DOI: 10.1177/0091270011408612 (opens in new tab) Microdose Pharmacokinetics Celiprolol Grapefruit juice +7